Welcome to the ManagedCare Oncology reference library a special one-stop center for cancer information brought to you by ICORE Healthcare. You can learn about cancer in general and explore information and resources for a specific cancer topic. Just select (click on) any of the cancer types in the list below to learn about specific risk factors, early detection, diagnosis, treatment options and more. We hope you find this information helpful. If you have suggestions for additional resources, please send a note to www.managedcareoncology.com.

Topics

AML

Clinical Trial Updates 2009

by John W. Mucenski, BS, PharmD, Director of, Pharmacy Operations, UMPC Cancer Centers

Drug and Administration Compendia 2009

Coding, reimbursement, and available therapies in the treatment of leukemia

Drug Therapy Review 2009

by Jeffrey F. Patton, MD, Medical Director, Tennessee Oncology

Facts & Figures 2009

Data and accompanying graphics on reimbursement practices, information

Improving Value 2009

by Leslie Fish, PharmD, Senior Director, Pharmacy Services, Fallon Community Health Plan

Industry Thought Leaders 2009

by David Chess, MD, Founder/Chief Medical Officer, Enhanced Care Initiatives

Pipeline Report 2009

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory & Reimbursement 2009

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2009

A comprehensive list of information sources relevant to managed care oncology professionals

Special Feature 2009

by Louis Hochheiser, MD, Medical Director, Clinical Policy Development, Humana, Inc.,Stanley Marks, MD, Deputy Director of Clinical Services for University of Pittsburgh Medical Center Cancer Centers/University of Pittsburgh Cancer Institute; and Robert Vanovich, PharmD, Manager of Clinical Services, Highmark Blue Cross Blue Shield

Breast Cancer

Bonadonna_BreastCancer

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer

Clinical Trails Update 2008

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Clinical Trial Update 2010

by John W. Mucenski, BS, PharmD, Director of Pharmacy Operations, UPMC Cancer Centers

Drug and Administration Compendia 2008

Coding, reimbursement, and available therapies

Drug and Administration Compendia 2010

Coding, reimbursement, and available therapies

Drug Therapy Review 2010

by Rowan T. Chlebowski, MD, PhD, Professor of Medicine, University of California, Los Angeles School of Medicine; Chief, Division of Medical Oncology and Hematology, Harbor-UCLA Medical Center

Drug Therapy Review 2008

by Stefan Gluck, MD, PhD, FRCP(C) Clinical Director, Braman Family Breast Cancer Institute, UM/Sylvester Professor of Medicine, Division of Hematology-Oncology, University of Miami Leonard M. Miller School of Medicine

Facts and Figures 2008

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Facts & Figures 2010

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2008

resulting outcomes with Lee Newcomer, MD, Senior Vice President of Oncology at UHC; Ranae Dahlberg, RN, BSN, Director of Clinical Services, Oncology Line of Service, UHC; and Bill McGivney, PhD, CEO, NCCN

Industry Thought Leader 2008

interviews with Joel Owerback, PharmD, Vice President and Cheif Pharmacy Officer, and Kathy Campagna, RN, MS, Medical Specialty Drug Contracting Program Director, Excellus BlueCross BlueShield

Industry Thought Leaders 2010

by Bridget Metcalf, Prinicpal, Healthcare Advocacy and Access, D.K. Pierce & Associates, Inc.

Pipeline Report 2008

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Pipeline Report 2010

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2008

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2008

A comprehensive list of information sources relevant to managed care oncology professionals

Resources and References 2010

A comprehensive list of information sources relevant to managed care oncology professionals

Special Feature 2008

by Brooke Pugmire, PharmD, BCPS

Special Feature 2010

by Rex W. Force, PharmD, Departments of Family Medicine and Pharmacy Practice, Idaho State University, and improveRX, LLC; and Brooke A. Pugmire, PharmD, Department of Pharmcay Practice, Idaho State University, and improveRX, LLC

Cervical Cancer

Clinical Trial Update 2009

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2009

Coding, reimbursement, and available therapies in the treatment of cervical cancer

Drug Therapy Review 2009

by Reshma L. Mahtani, DO, Lynn Regional Cancer Center West

Facts and Figures 2009

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2009

by John S. Macdonald, MD, FACP, Chief Medical Officer, Aptium Oncology Inc.

Industry Thought Leaders 2009

A Discussion with Jeff Forringer, President of IntrinsiQ

Regulatory & Reimbursement 2009

A comprehensive list of information sources relevant to managed care oncology professionals

Resources and References 2009

A comprehensive list of information sources relevant to managed care oncology professionals

Colorectal Cancer

Clinical Trails Update 2011

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Clinical Trails Update 2007

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2007

Coding, reimbursement, and available therapies in the treatment of colorectal cancer

Drug and Administration Compendia 2011

Coding, reimbursement, and available therapies

Drug Therapy Review 2007

by Michael A. Choti, MD, MBA, The Jacob C. Handelsman Professor of Surgery, Chief of the Division of Surgical Oncology, Johns Hopkins University

Drug Therapy Review 2011

by Johanna Bendell, MD, Director, GI Oncology Research; Associate Director, Drug Development Unit, Sarah Cannon Research Institute

Facts & Figures 2007

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Facts and Figures 2011

by Janet T. Serluco, Director, Specialty Injectables Market Research, ICORE Healthcare

Improving Value 2007

staff report with contributions from Robert Wanovich, PharmD, Vice President, Pharmacy Affairs, Highmark, Inc.

Improving Value 2011

by Matthew Mitchell, PharmD, MBA, Manager, Pharmacy Services, SelectHealth

Industry Thought Leaders 2007

A Discussion with Helen Sherman, RPh, PharmD, Senior Director/Cheif Pharmacy Officer, Pharmacy Services, The Regence Group

Industry Thought Leader 2011

A Discussion with Kevin Kobielski, CPA, Director, Pharmacy Services, HealthNow New York Inc.

Pipeline Report 2007

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Pipeline 2011

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory & Reimbursement 2007

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Regulatory and Reimbursement 2011

Denise K. Pierce, President, DK Pierce & Associates, Inc

Resources and References 2007

A comprehensive list of information sources relevant to managed care oncology professionals

Resources and References 2011

A comprehensive list of information sources relevant to managed care oncology professionals

Special Feature 2007

by Kjel Johnson, PharmD, Publisher, Managed Care Oncology

ICORE Healthcare Medical Injectables and Oncology Trend Report

Lung Cancer

Chemo at End of Life Study_NSCLC 2008

Chemotherapy Given Near the End of Life by Community Oncologists for Advanced Non-Small Cell Lung Cancer

Clinial Trial Updates 2011

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Clinical Trails Update 2008

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2008

Coding, reimbursement, and available therapies in the treatment of lung cancer

Drug and Administration Compendia 2011

Coding, reimbursement, and available therapies

Drug Therapy Review 2011

By David Spigel, MD, Tennessee Oncology

Drug Therapy Review 2008

by Chandra P. Belani, MD, Miriam Beckner Professor of Medicine, Penn State College of Medicine, and Deputy Director, Penn State Cancer Institute at Penn State Milton S. Hershey Medical Center

Facts and Figures 2008

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Facts and Figures 2011

By Janet T. Serluco, Director, Specialty Injectables Market Research, ICORE Healthcare

Improving Value 2008

by Ken Partic, MD, Chief Medical Officer, BlueCross BlueShield of Tennessee, and Terrence Shea, PharmD, Pharmacy Department, BlueCross BlueShield of Tennessee

Improving Value 2011

By Bruce Niebylski, MD, Associate Vice President for Medical Affairs, East Region, PriorityHealth

Industry Thought Leaders 2008

A Discussion with Burton F. Vanderlaan, MD, Regional Medical Director, Oncologist, North Central Region, Aetna, Inc.

Pipeline Report 2008

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Pipeline Report 2011

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2008

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Regulatory & Reimbursement 2011

Denise K. Pierce, President, DK Pierce & Associates, Inc

Resources and References 2008

A comprehensive list of information sources relevant to managed care oncology professionals

Resources and References 2011

A comprehensive list of information sources relevant to managed care oncology professionals

Lymphoma

Cinical Trial Update 2008

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Clinical Trials Update 2011

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug & Administration Compendia 2008

Coding, reimbursement, and available therapies in the treatment of lymphoma

Drug and Administration Compendia 2011

Coding, reimbursement, and available therapies in the treatment of lymphoma.

Drug Therapy Review 2008

by Stanley Marks, MD, Chief, Division of Hematology/Oncology, UPMC Shadyside Hospital and Director for Clinical Services of UPMC Cancer Centers

Drug Therapy Reviews 2011

Jay Wang, MD, Assistant Professor, Baylor College of Medicine

Facts and Figures 2008

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Facts and Figures 2011

Janet T. Serluco, Director, Specialty Injectables Market Research, ICORE Healthcare

Improving Value 2008

A Discussion with Nancy Stalker, PharmD, Vice President, Pharmacy Services, and George Sl Jaresko, PharmD,Manager, Drug Information, Blue Shield of California

Improving Value 2011

Beckie Fenrick, PharmD, MBA; Senior Director of Clinical Pharmacy, Blue Cross and Blue Shield of Florida

Industry Thought Leaders 2008

A Discussion with Christy Bell, Senior Vice President, Healthcare management, and Richard Popiel, MD, Chief Medical Officer, Horizon Blue Cross Blue Shield of New Jersey

Industry Thought Leaders 2011

Mark Zitter, MBA, Founder and CEO of The Zitter Group

Pipeline 2008

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Pipeline Report 2011

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2008

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Regulatory and Reimbursement 2011

Denise K. Pierce, President, DK Pierce & Associates, Inc

Resources & References 2008

A comprehensive list of information sources relevant to managed care oncology professionals

Resources and References 2011

A comprehensive list of lymphoma sources relevant to managed care oncology professionals.

Special Feature 2008

by John W. Mucenski, BS, PharmD, Director, Pharmacy Operations, UMPC Cancer Centers

Melanoma

Clinical Trails Update 2009

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2009

Coding, reimbursement, and available therapies in the treatment of melanoma

Drug Therapy Reviews 2009

by Keith T. Flaherty, MD, Assistant Professor of Medicine, University of Pennsylvania School of Medicine

Facts & Figures 2009

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2009

by Dawn Holcombe, FACMPE, MBA, ACHE; President, DHG Consulting

Industry Thought Leaders 2009

A Discussion with Rex W. Force, PharmD,BCPS, FCCP; Founding Partner, improveRX

Pipeline 2009

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2009

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2009

A comprehensive list of information sources relevant to managed care oncology professionals

Multiple Myeloma

Clinical Trails Update 2011

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Correspondence 2011

Kjel A. Johnson, PharmD, Publisher, ManagedCare Oncology

Drug and Administration Compendia 2011

Coding, reimbursement, and available therapies

Drug and Administration Compendia 2007

Coding, reimbursement, and available therapies in the treatment of Multiple Myeloma

Drug Therapy Review 2007

by Lee schwartzberg, MD, FACP, Medical Director, The West Clinic

Drug Therapy Review 2011

by Ralph V. Boccia, MD, FACP, Medical Director, Center for Cancer and Blood Disorders

Facts and Figures 2007

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Facts and Figures 2011

by Janet Serluco, Director , Specialty Injectables Market Research, ICORE Healthcare

Improving Value 2007

by Richard Cook, PharmD, Manager, Clinical and Quality Programs, Blue Care Network of Michigan

Improving Value 2011

by Mona Chirtre, PharmD, CGP, Director of Clinical Services, Strategy, and Policy, FLRx Pharmacy Management, Excellus BlueCross BlueShield

Industry Thought Leader 2011

by Mohamed Diab, VP, Medical Management, EmblemHealth, Inc

Industry Thought Leader 2007

A Discussion with Lee Neewcomer, MD, Senior Vice President of Oncology, United Healthcare

Pipeline 2007

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Pipeline 2011

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2007

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Regulatory and Reimbursement 2011

by Denise K. Pierce, President, DK Pierce & Associates, Inc

Resources and References 2011

A comprehensive list of information sources relevant to managed care oncology professionals

Special Feature 2007

by Rex W. Force, PharmD, Kerri Chitwood, PharmD, BCPS, Patrick F. Gill, RPh, Millagro Valderrama, PharmD, Susan Weidner, MS, Cynthia D. Hill, PhD

Special Feature 2011

by Gary M. Owens, MD, Gary Owens Associates

Ovarian Cancer

Clinical Trails Update 2008

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2008

Coding, reimbursement, and available therapies in the treatment of ovarian cancer

Drug Therapy Review 2008

by Reshma L. Mahtani, DO, Lynn Cancer Institute West

Facts & Figures 2008

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2008

by Winston Wong, PharmD, associate Vice President, Pharmacy Management, CareFirst BlueCross BlueShield

Industry Thought Leaders 2008

A Discussion with Peter G. Ellis, MD, Director of Medical Oncology, University of Pittsburgh Medical Center Cancer Centers

Pipeline 2008

by Shubham Pant, MD, Assistant Professor of Medicine, Director of Clinical Trials, Hematology-Oncology Section; and Howard Ozer, MD, PhD, Eason Chair and Chief, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center

Regulatory and Reimbursement 2008

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2008

A comprehensive list of information sources relevant to managed care oncology professionals

Pancreatic Cancer

Clinical Trails Update 2009

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2009

Coding, reimbursement, and available therapies in the treatment of pancreatic cancer

Drug Therapy Review 2009

by Robert L. Fine, MD, Director, Medical Oncology, The Pancreas Center

Facts & Figures 2009

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2009

by Beckie Fenrick, PharmD, MBA, Director of Clinical Pharmacy Programs, Blue Cross Blue Shield of Florida

Regulatory and Reimbursement 2009

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2009

A comprehensive list of information sources relevant to managed care oncology professionals

Prostate Cancer

Clinical Trails Update 2006

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Clinical Trial Updates 2010

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2006

Coding, reimbursement, and available therapies in the treatment of prostate cancer

Drug & Administration Compendia 2010

Coding, reimbursement, and available therapies in the treatment of prostate cancer

Drug Therapy Reviews 2006

by Martin I. Renick, MD and Lester Persky, Professor and Chief, Department of Urology, Case Western Reserve University School of Medicine

Drug Therapy Reviews 2010

by Charles J. Ryan, MD, Assistant Clinical Professor, University of California, San Francisco School of Medicine

Facts and Figures 2006

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Facts & Figures 2010

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2006

by Elan Rubinstein, PharmD, MPH

Industry Thought Leaders 2010

by Gary J. Tereso, PharmD, Manager of Pharmacy Services, Health New England, Inc.

Pipeline 2006

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Pipeline Report 2010

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2006

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Regulatory and Reimbursement 2010

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2006

A comprehensive list of information sources relevant to managed care oncology professionals

Resources and References 2010

A comprehensive list of information sources relevant to managed care oncology professionals

Breat Cancer Treatments & Advancements 2006

by Gary Lyman, MD, Professor of Medicine and Oncology, University of Rochester School of Medicine and Dentistry

Practical Perspective 2010

by Beau Donegan , MBA, CEO, Newport Pacific Medical Associates

Radiation Oncology

Clinical Trails Update 2010

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia

Coding, reimbursement, and available therapies in radiopharmaceuticals

Drug Therapy Review 2010

by Dwight E. Heron, MD, Vice Chairman of Radiation Oncology, UPMC Shadyside; and Ramond B. Wynn, MD, FACR, Associate Director, UPMC Cancer Centers Radiation Oncology Network

Facts and Figures 2010

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value 2010

by Kathy Lokay and Greg Ross

Regulatory and Reimbursement 2010

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Resources and References 2010

A comprehensive list of information sources relevant to managed care oncology professionals

Renal Cell Carcinoma

Clinical Trial Update

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug Therapy Reviews

by Jeffrey A. Scott, President, P4 Healthcare, LLC

Facts & Figures

Data and accompanying graphics on reimbursement practices, information management, and oncology spending

Improving Value

by Michael Waterbury, VP, Healthcare Services, Oxford Health Plans, LLC

Pipeline Report

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory & Reimbursement

Roberta L. Buell, VP of Patient & Provider Services at P4 Healthcare, LLC.

Rheumatoid Arthritis

ManagedCare Specialty Drugs - RA Supplement

Focus on Rheumatoid Arthritis

Supportive Care

Clinical Trial Update 2010

John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers

Drug and Administration Compendia 2010

Coding, reimbursement, and available therapies in supportive care

Facts & Figures 2010

by Janet T. Serluco, Director, Specialty Injectables market Research, ICORE Healthcare

Improving Value 2010

by Jeff Forringer, CEO, IntrinsiQ

Pipeline 2010

Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute

Regulatory and Reimbursement 2010

by Bryan Cote

Resources and References 2010

A comprehensive list of information sources relevant to managed care oncology professionals

Special Feature 2010

Angela Maas